Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients

Powers SK, Morton AB, Ahn B et al (2016) Redox control of skeletal muscle atrophy. Free Radic Biol Med 98:208–217 Gracia Iguacel C, González Parra E, Barril Cuadrado G et al (2014) Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications. Nefrologia 34(4):507–519 Sabatino A, Cuppari L, Stenvinkel P et al (2020) Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. https://doi.org/10.1007/s40620-020-00840-y Carrero JJ, Thomas F, Arogundade F et al (2018) Global prevalence of protein-energy wasting in kidney disease : a meta-analysis of contemporary observational studies from the international society of renal nutrition and metabolism. J Ren Nutr 28(6):380–392 Wafi AM, Hong J, Rudebush TL et al (2019) Translational control of muscle mass curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF : Nrf2 and antioxidant mechanisms in skeletal muscle. J Appl Physiol 126:477–486 Dutt V, Gupta S, Dabur R et al (2015) Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action. Pharmacol Res 99:86–100 Stenvinkel P, Heimbürger O, Lindholm B et al (2000) Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15(7):953–960 Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391–398 Nixon AC, Bampouras TM, Pendleton N et al (2018) Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J 11(2):236–245 Cruz Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31 Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10(9):504–516 Robinson KA, Baker LA, Graham-Brown MPM et al (2020) Skeletal muscle wasting in chronic kidney disease: the emerging role of microRNAs. Nephrol Dial Transpl 35(9):1469–1478 Lin YL, Chen SY, Lai YH et al (2019) Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients. BMC Nephrol 20(1):1–7 Huang D, Fan S, Chen X et al (2019) Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner. Exp Gerontol 119:61–73 Ahn B, Pharaoh G, Premkumar P et al (2018) Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass. Redox Biol 17:47–58 Juul-Nielsen C, Shen J, Stenvinkel P et al (2021) Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions, and relation to morbidity. Nephrol Dial Transpl 6:gfab031 Mafra D, Borges NA, Lindholm B et al (2020) Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat Rev Nephrol 17:153–171 Narasimhan M, Hong J, Atieno N et al (2014) Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells. Free Radic Biol Med 71:402–414 Dutt V, Saini V, Gupta P et al (2018) S-allyl cysteine inhibits TNF α-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules. Biochim Biophys Acta Gen Subj 1862(4):895–906 Bailey JL, Zheng B, Hu Z et al (2006) Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17(5):1388–1394 Minchin SD, Busby SJW (2010) Review of molecular mechanisms involved in the activation of the NRF2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 647:37–74 Jung KA, Kwak MK (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15(10):7266–7291 Sárközy M, Kovács ZZA, Kovács MG et al (2018) Mechanisms and modulation of oxidative/nitrative stress in type 4 cardio-renal syndrome and renal sarcopenia. Front Physiol 9:1–19 Receno CN, Liang C, Korol DL et al (2019) Effects of prolonged dietary curcumin exposure on skeletal muscle biochemical and functional responses of aged male rats. Int J Mol Sci 20(5):1–18 Rom O, Reznick AZ (2016) The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med 98:218–230 Powers SK, Morton AB, Ahn B et al (2016) Free radical biology and medicine redox control of skeletal muscle atrophy. Free Radic Biol Med 98:208–217 Deval C, Mordier S, Obled C et al (2015) Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J 360(1):143–150 Chaudhary P, Sharma YK, Sharma S et al (2019) High altitude mediated skeletal muscle atrophy: Protective role of curcumin. Biochimie 156:138–147 Bondesen BA, Mills ST, Kegley KM et al (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 287:475–483 Shen W, Li Y, Zhu J (2008) Interaction between macrophages, TGF-β1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J Cell Physiol 214:405–412 Sun X, Liu Y, Li C et al (2017) Recent advances of curcumin in the prevention and treatment of renal fibrosis. Biomed Res Int 2017:1–9 Ghosh SS, Krieg R, Massey HD et al (2012) Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5⁄6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Ren Physiol 302:439–454 Xu J, Li R, Workeneh B et al (2012) Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int 82(4):401–411 Farage NE, Stockler-Pinto MB, Leal VO et al (2016) NF-κB expression and its association with nutritional status in hemodialysis patients. Int Urol Nephrol 48(12):2089–2094 Al-Sawaf O, Fragoulis A, Rosen C et al (2014) Nrf2 protects against TWEAK-mediated skeletal muscle wasting. Sci Rep 4:1–7 Pedruzzi LM, Stockler-Pinto MB, Leite M et al (2012) Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease? Biochimie 94(12):2461–2466 Stenvinkel P, Painer J, Kuro OM et al (2018) Novel treatment strategies for chronic kidney disease: insights from the animal kingdom. Nat Rev Nephrol 14(4):265–284 Crilly MJ, Tryon LD, Erlich AT et al (2016) The role of Nrf2 in skeletal muscle contractile and mitochondrial function. J Appl Physiol 121(3):730–740 Bott LC, Badders NM, Chen KL et al (2016) A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet 25(10):1979–1989 Chertow GM, Appel GB, Block GA et al (2018) Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. J Diabetes Complicat 32(12):1113–1117 Liu C, Gidlund E-K, Witasp A et al (2019) Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease. Am J Physiol Physiol 317(5):F1122–F1131 Pedruzzi LM, Cardozo LFMF, Daleprane JB et al (2015) Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. J Nephrol 28(4):495–501 Safdar A, Tarnopolsky MA (2010) Dysfunctional Nrf2 – Keap1 redox signaling in skeletal muscle of the sedentary old. Free Radic Biol Med 49(10):1487–1493 Miller CJ, Gounder SS, Kannan S et al (2012) Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle. Biochim Biophys Acta 1822(6):1038–1050 Chung LH, Liu ST, Huang SM et al (2020) High phosphate induces skeletal muscle atrophy and suppresses myogenic differentiation by increasing oxidative stress and activating Nrf2 signaling. Aging (Albany NY) 12(21):21446–21468 Kitaoka Y, Tamura Y, Takahashi K et al (2019) Effects of Nrf2 deficiency on mitochondrial oxidative stress in aged skeletal muscle. Physiol Rep 7(3):1–8 Stenvinkel P (2021) Mitochondrial dysfunction as part of an inflammatory intermediate phenotype that drives premature ageing. J Intern Med. https://doi.org/10.1111/joim.13243 Stockler Pinto MB, Fouque D, Soulage CO et al (2014) Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway? J Ren Nutr 24(5):286–291 Chen QM, Maltagliati AJ (2018) Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genom 50(2):77–97 Francaux M, Deldicque L (2018) Using polyphenol derivatives to prevent muscle wasting. Curr Opin Clin Nutr Metab Care 21(3):159–163 Mafra D, Borges N, Alvarenga L et al (2019) Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients 11(3):496 Konopka AR, Laurin JL, Musci RV et al (2017) Influence of Nrf2 activators on subcellular skeletal muscle protein and DNA synthesis rates after 6 weeks of milk protein feeding in older adults. GeroScience 39(2):175–186 Sun Y, Yang T, Leak RK et al (2017) Preventive and protective roles of dietary Nrf2 activators against central nervous system diseases. CNS Neurol Disord Drug Targets 16(3):326–338 Clifford T, Acton JP, Cocksedge SP et al (2021) The efect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: a systematic review of human intervention trials. Mol Biol Rep 48:1745–1761 Zhao Y, Liu X, Fu X et al (2019) Protective effects of epigallocatechin gallate against ischemia reperfusion injury in rat skeletal muscle via activating Nrf2/HO-1 signaling pathway. Life Sci 239:117014 Kanlaya R, Thongboonkerd V (2019) Molecular mechanisms of epigallocatechin-3-gallate for prevention of chronic kidney disease and renal fibrosis: preclinical evidence. Curr Dev Nutr 3(9):1–10 Wang H, Lai Y, Chan Y et al (2011) Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Lett 305:40–49 Sun W, Liu X, Zhang H et al (2017) Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free Radic Biol Med 108:840–857 Saldanha JF, Leal VO, Rizzetto F et al (2016) Effects of resveratrol supplementation in Nrf2 and NF-κB expressions in nondialyzed chronic kidney disease patients: a randomized, double-blind, placebo-controlled. Crossover Clinical Trial J Ren Nut 26(6):401–406 Boocock DJ, Faust GES, Patel KR et al (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16(6):1246–1252 Kim EN, Lim JH, Kim MY et al (2018) Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging 10(1):83–99 Batistela E, Pereira MP, Siqueira JT et al (2014) Decreased rate of protein synthesis, caspase-3 activity, and ubiquitin–proteasome proteolysis in soleus muscles from growing rats fed a low-protein, high-carbohydrate diet. Can J Physiol Pharmacol 92(6):445–454 Dirks ML, Wall BT, Nilwik R et al (2014) Skeletal muscle disuse atrophy is not attenuated by dietary protein supplementation in healthy older men 1, 2. J Nutr 144:1196–1203 Baptista IL, Leal ML, Artioli GG et al (2010) Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle Nerve 41(6):800–808 Katsanos CS, Kobayashi H, Sheffield Moore M et al (2006) A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 291:381–387 Borgenvik M, Apró W, Blomstrand E et al (2012) Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscle Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exerc. Am J Physiol Endocrinol Metab 302:520–521 Lambertucci AC, Lambertucci RH, Hirabara SM et al (2012) Glutamine supplementation stimulates protein-synthetic and inhibits protein-degradative signaling pathways in skeletal muscle of diabetic rats. PLoS ONE 7(12):e50390 Golpour P, Nourbakhsh M, Mazaherioun M et al (2020) Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: a double-blind randomised placebo-controlled clinical trial. Diabetes Res Clin Pract 162:108120 Son SH, Lee SM, Lee MH et al (2021) Omega-3 fatty acids upregulate SIRT1/3, activate PGC-1 via deacetylation, and induce Nrf1 Production in 5/6 nephrectomy rat model. Mar Drugs 19(182):1–10 Yu R, Chen JA, Xu J et al (2017) Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease. J Cachexia Sarcopenia Muscle 8(2):327–341 Kunkel SD, Suneja M, Ebert SM et al (2011) mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 13(6):627–638 Bunney PE, Zink AN, Holm AA et al (2017) Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav 176(1):139–148 Pan Y, Wang Y, Cai L et al (2012) Inhibition of high glucose- induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury. Br J Pharmacol 166:1169–1182 McFarlin BK, Venable AS, Henning AL et al (2016) Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA Clin 5:72–78 He J, Xie H, Wu S (2016) Dietary supplementation of curcumin alleviates NF-κB-dependent skeletal muscle wasting in rat. Endocrine Metab Immune Disord Drug Targets 16:140–147 Sahin K, Pala R, Tuzcu M et al (2016) Curcumin prevents muscle damage by regulating NF-κB and Nrf2 pathways and improves performance: an in vivo model. J Inflamm Res 9:147–154 Parsons HA, Baracos VE, Hong DS et al (2016) The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Oncotarget 7(15):1–71 Zhang L, Chen Q, Chen Z et al (2020) Mechanisms regulating muscle protein synthesis in CKD. J Am Nephrol 31(11):2573–2587 Aranda Rivera AK, Cruz Gregorio A, Pedraza-Chaverri J et al (2022) Nrf2 activation in chronic kidney disease: promises and pitfalls. Antioxidants 11:1112